Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vietnam malaria therapeutic efficacy surveillance study
ACTRN12611000175976Phase 4Recruiting
- Sponsor
- Ministry of Health
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artesunate, dihydroartemisinin + piperaquine and chloroquine in malaria and Malaria (3 arms), sponsored by Ministry of Health. Primary endpoint: 28/42-day adequate clinical and parasitological response. Started Aug 2010; status: recruiting.
02
Drugs
artesunatedihydroartemisinin + piperaquinechloroquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12611000175976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000175976.